Biomarkers in NSTE-ACS

Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome

Even during follow-up, NT-proBNP demonstrated the strongest association to the composite endpoint of death/myocardial infarction.

If I find a good article/tutorial on NT-proBNP I’ll post it.

DM = 3X Higher CVD Mortality Risk

Metabolic Syndrome and Diabetes, Alone and in Combination, as Predictors of Cardiovascular Disease Mortality Among Men — Diabetes Care

CONCLUSIONS The presence of diabetes was associated with a threefold higher CVD mortality risk, and metabolic syndrome status did not modify this risk. Our findings support the fact that physicians should be aggressive in using CVD risk–reducing therapies in all diabetic patients regardless of metabolic syndrome status.

Please tell me you already knew this…